Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FISONS CLASS RECALL OF OPTICROM PRESCRIPTION EYE DROPS

Executive Summary

FISONS CLASS RECALL OF OPTICROM PRESCRIPTION EYE DROPS involves over 45,000 bottles from two lots of the 4% ophthalmic solution 10 ml bottles, the company announced in a July 13 press release. Evidence of bacterial contamination that could cause serious eye infections in scratched or damaged eyes was found in the two lots of the cromolyn sodium product. The two lots of Opticrom under recall are KF35V, of which 45,223 bottles were distributed, and KF7A, of which 114 bottles were distributed. The recall extends to the consumer level. Distribution was nationwide and included Puerto Rico. The contamination was discovered following tests by Fisons, which manufactures the product in the U.K. The tests "indicated the possible presence of Bacillus cereus in lot KF7A and an unidentified anaerobic bacillus in lot KF35V," the release states. Opticrom is indicated for certain eye allergies, with recommended dosing of one-to-two drops four-to-six times a day. A same-day FDA press release warns that "if patients have a slight scratch on the eye, they are at high risk of developing a potentially sight-threatening infection from a contaminated eye solution."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017752

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel